Literature summary extracted from

Glavas-Obrovac, L.; Karner, I.; Stefanic, M.; Kasnar-Samprec, J.; Zinic, B.
Metabolic effects of novel N-1-sulfonylpyrimidine derivatives on human colon carcinoma cells (2005), Farmaco, 60, 479-483.

Activating Compound

EC Number	Activating Compound	Comment	Organism	Structure
2.7.1.48	5-bromo-1-(methanesulfonyl) uracil	significantly increased activity at 0.001 mM	Homo sapiens

Inhibitors

EC Number	Inhibitors	Comment	Organism	Structure
2.7.1.48	1-(p-toluenesulfonyl) cytosine	44% inhibition at 0.001 mM	Homo sapiens

Organism

EC Number	Organism	UniProt	Comment	Textmining
2.7.1.48	Homo sapiens	-	-	-

Source Tissue

EC Number	Source Tissue	Comment	Organism	Textmining
2.7.1.48	Caco-2 cell	-	Homo sapiens	-
2.7.1.48	colon carcinoma cell	-	Homo sapiens	-

Substrates and Products (Substrate)

EC Number	Substrates	Comment Substrates	Organism	Products	Comment (Products)	Rev.	Reac.
2.7.1.48	ATP + uridine	-	Homo sapiens	ADP + UMP	-	?

Cofactor

EC Number	Cofactor	Comment	Organism	Structure
2.7.1.48	ATP	-	Homo sapiens

Use of this online version of BRENDA is free under the CC BY 4.0 license. See terms of use for full details.

Release 2023.1 (January 2023)